This document is page 36 of a Cowen Collaborative Insights market research report dated February 25, 2019. It analyzes the CBD topical market, detailing price segments (Super Premium to Value) and consumer demographics (age, gender, income). While the document bears a 'HOUSE_OVERSIGHT_024852' Bates stamp, indicating it is part of a government investigation (potentially related to the Epstein case files via subpoenaed financial records), the content on this specific page is purely market research regarding CBD products and does not explicitly mention Epstein or his associates.
| Name | Role | Context |
|---|---|---|
| Michael Cella | Recipient/Employee |
Email address listed in sidebar warning: 'This report is intended for michael.cella@cowen.com'
|
| Name | Type | Context |
|---|---|---|
| Cowen |
Author of the report 'Cowen Collaborative Insights'
|
|
| House Oversight Committee |
Identified by Bates stamp 'HOUSE_OVERSIGHT_024852'
|
|
| Mary's Nutritionals |
Listed in chart
|
|
| Sagely Naturals |
Listed in chart
|
|
| Curaleaf Hemp |
Listed in chart
|
|
| Green Roads |
Listed in chart
|
|
| cbdMD |
Listed in chart
|
"Mary’s topicals fall into the super-premium segment, which we define as anything above $0.54 per mg of CBD."Source
"According to our proprietary Cowen consumer survey, of respondents who use CBD, 26.2% of people use topicals as a form factor..."Source
"Topical Use Is More Prevalent Among Younger, Lower Income Consumers"Source
Complete text extracted from the document (2,401 characters)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document